Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eleven product candidates in various stages of development. Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eleven product candidates in various stages of development.
Adds an additional commercial and strategic rare disease product to Eton’s portfolioGalzin is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease DEER PARK...
Acquisition bolsters Eton’s commercial pediatric endocrinology portfolioProduct is now available through AnovoRx, a specialty pharmacy dedicated to serving patients with rare and chronic...
DEER PARK, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.75 | 14.2857142857 | 12.25 | 14.7301 | 11.63 | 271566 | 13.8588561 | CS |
4 | 1.71 | 13.9137510171 | 12.29 | 15 | 11.612 | 251184 | 13.18138703 | CS |
12 | 5.8 | 70.7317073171 | 8.2 | 15 | 7.58 | 245490 | 11.5905373 | CS |
26 | 10.41 | 289.972144847 | 3.59 | 15 | 3.2519 | 179395 | 9.37825455 | CS |
52 | 9.9 | 241.463414634 | 4.1 | 15 | 3.03 | 118990 | 8.07444196 | CS |
156 | 10 | 250 | 4 | 15 | 1.95 | 136577 | 4.91661999 | CS |
260 | 6.5 | 86.6666666667 | 7.5 | 15 | 1.95 | 209526 | 5.92130918 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales